Characterization of the regulatory roles of the SUMO

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 854-861

  Hwang, Kwang Woo ^a   Won, Tae Joon ^a   Kim, Hyunok ^b   Chun, Ha Jung ^b   Chun, Taehoon ^c   Park, Yongsoo ^b  

^a Chung Ang University   (South Korea)

^b Hanyang University   (South Korea)

^c Korea University   (South Korea)

Author keywords

IDDM5; Immune cells; NF B; SUMO2; Sumoylation; Type 1 diabetes

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO 4 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE PREDISPOSITION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-12; MICE; MICE, TRANSGENIC; NF-KAPPA B; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; SUMOYLATION; T-LYMPHOCYTES;

EID: 80855124146     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1261     Document Type: Article

References (10)

1. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-2777.
2. Guo D, Li M, Zhang Y, et al. A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes. Nat Genet 2004; 36: 837-841.
3. Hochstrasser M. Biochemistry. All in the ubiquitin family. Science 2000; 289: 563-564.
4. Verger A, Perdomo J, Crossley M. Modification with SUMO: A role in transcriptional regulation. EMBO Rep 2003; 4(2): 137-142.
5. Freiman RN, Tjian R. Regulating the regulators: lysine modifications make their mark. Cell 2003; 112(1): 11-17.
6. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996; 7: 13-20.
7. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS. I Kappa B interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev 1992; 6: 1899-1913.
8. Feldmann M, Andreakos E, Smith C, et al. Is NF-κB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 2002; 61: 13-27.
9. Lee JY, Park Y, Kim SJ, Park CG, Chun T. Molecular cloning and expression analysis of the pig small ubiquitin-like modifier (SUMO) gene family. Int J Immunogenet 2009; 36(1): 59-64.
10. Noso S, Ikegami H, Fujisawa T, et al. Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes. Diabetes 2005; 54(12): 3582-3586.